
-
2006
Company Description
ImmuneWorks develops immune tolerance treatments for patients with serious autoimmune diseases in the lung.
ImmuneWorks was founded in 2006 to develop safe and effective immune tolerance treatments for patients with serious autoimmune diseases of the lung. The scientific foundation of the company is ImmuneWorks' groundbreaking discovery that antigen-specific autoimmunity is responsible for the disease in over one-half of idiopathic pulmonary fibrosis (IPF) patients.
-
Manufacturer:
Science and Engineering -
Formed:
2006 -
Founders:
David Wilkes -
Company Website:
-
Company E-mail:
-
Company Address:
351 West 10th StreetIndianapolis, INUnited States -
CEO:
- David Wilkes
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits